Close Menu
    What's Hot

    ReAssure Staff Pension Scheme Completes Bulk Purchase Annuity Transaction With Standard Life

    July 27, 2026

    Miller Retirement Benefits Scheme Completes Bulk Purchase Annuity Buy-In With M&G

    July 27, 2026

    Credit Commercial de France Pension Scheme Completes Bulk Purchase Annuity Buy-In With Royal London

    July 23, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Big Year of Growth for Life/Annuity Sidecar-Like Activity in 2025

      July 2, 2026

      Sixth Street To Become Majority Shareholder of Monument Re

      June 30, 2026

      Pacific Life Re Appoints Florence Durousseau as Head of Capital Solutions, Europe

      June 15, 2026

      Third Block Reinsurance Deal With Tokio Marine & Nichido Life for Pacific Life Re

      June 10, 2026

      Shaping the Future of Health Insurance Through Innovation and Analytics

      June 10, 2026

      Q&A: Dr Christoph Schmitt, Director, Insurance, Fitch Ratings

      May 28, 2026

      Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

      May 13, 2026

      US Annuity Sales Notch Tenth Consecutive $100bn+ Quarter

      May 11, 2026

      ReAssure Staff Pension Scheme Completes Bulk Purchase Annuity Transaction With Standard Life

      July 27, 2026

      Miller Retirement Benefits Scheme Completes Bulk Purchase Annuity Buy-In With M&G

      July 27, 2026

      Credit Commercial de France Pension Scheme Completes Bulk Purchase Annuity Buy-In With Royal London

      July 23, 2026

      Smiths Industries Pension Scheme Completes Bulk Purchase Annuity Buy-In With M&G

      July 23, 2026

      Record Low Mortality Rates So Far in England and Wales in 2026

      July 9, 2026

      Organ Transplant Improvements Test Life Expectancy Assessment Models

      July 8, 2026

      The Pursuit of Everlasting Life Unlikely to Shift Actuarial Models

      June 10, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026
      Litigation

      Litigation Update: Estate of Martha Barotz v. Wilmington Savings Fund Society, FSB, et al.

      July 22, 2026

      South Dakota Supreme Court Upholds Life Settlement Investor’s Right to Retain $10 Million Death Benefit

      July 22, 2026

      Optimism for Stronger Second Half in the Life Settlement Tertiary Market

      July 8, 2026

      US Life Insurers Embrace Securitised Credit as Demand for Yield and Diversification Grows but Hurdles Remain for Longevity-Linked Assets

      July 8, 2026

      ReAssure Staff Pension Scheme Completes Bulk Purchase Annuity Transaction With Standard Life

      July 27, 2026

      Miller Retirement Benefits Scheme Completes Bulk Purchase Annuity Buy-In With M&G

      July 27, 2026

      Credit Commercial de France Pension Scheme Completes Bulk Purchase Annuity Buy-In With Royal London

      July 23, 2026

      Smiths Industries Pension Scheme Completes Bulk Purchase Annuity Buy-In With M&G

      July 23, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 7, July 2026

      July 8, 2026

      Editor’s Letter – Volume 2, Issue 6, June 2026

      June 10, 2026

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026

      Editor’s Letter – Volume 2, Issue 3, March 2026

      March 11, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    Editor’s Letter – Volume 2, Issue 9, September 2023

    Magazine September 15, 2023By Chris Wells
    Editor's Letter
    Share
    Twitter LinkedIn Email

    Download Life Risk News Volume 2, Issue 9, September 2023

    The pension risk transfer market in the US is now a $50bn+ market, but unlike the UK, it’s one where private equity and private debt funds are playing increasing roles. That’s not gone unnoticed by some groups, so Aaron Woolner spoke to Charles Decker, a Researcher at UNITE HERE, and Joe Engelhard, Senior Counsel, US Policy & Regulation at the Alternative Investment Management Association to understand both the reservations that some have about this development, and the rebuttal, in Spotlight Falls on US Life Insurer’s Private Debt Investments, our cover story this month.

    Higher interest rates have had an impact on all alternative investment strategies in the past twelve months and will continue to do so as they remain elevated when compared to the post-GFC decade. Perhaps no impact, however, is greater than that of the German secondary life insurance policy market which, due to its structure, is now largely defunct. Greg Winterton spoke to Anna Bailey, a Board member at trade group BVZL, for her views on the likelihood of the market returning in The US Now The Last Remaining Traded Life Policy Market.

    The US Securities and Exchange Commission established a Life Settlement Task Force in 2009 to examine then-emerging issues in the life settlement market and advise whether market practices and regulatory oversight could be improved. Fourteen years later, the task force is yet to deliver its recommendations to Congress. Jeffrey Davis spoke to JoAnn M. Strasser, Partner and Chair, Investment Management at Thompson Hine LLP and Ron S. Geffner, Founding Partner at Sadis & Goldberg LLP, for their thoughts as to why in Re-Visiting the SEC Life Settlements Task Force More Than a Decade Later.

    Life insurance companies have a reputation for being something akin to an oil tanker – big, and slow. But their approach to incorporating generative AI (GenAI) into various functions of their businesses can hardly be claimed to be thus. A snap poll conducted by technology consulting firm, Celent, in July this year revealed that 10% of life insurers in the United States were already using GenAI in production. Greg Winterton spoke to Keith Raymond, Principal Analyst, Insurance at Celent to learn more about this trend in Generative AI Set to Transform Life Insurance Industry.

    Many investors in the life settlements asset class do not fully grasp the complexities underlying the asset before making the decision to invest in it; life settlements are more complicated to acquire and manage than other comparable discounted cash flow assets. Maurizio Pellegrini, Life ILS Manager at Azimut Investments, explains three areas that investors should pay close attention to before deploying capital in the space in The Critical Nature of Life Insurance Policy Due Diligence in the Life Settlement Asset Class, our first commentary article this month.

    The UK’s Continuous Mortality Investigation (CMI) carries out research into mortality and morbidity experience and produces practical tools that are widely used by actuaries. It published its most recent set of projections in July, showing lower life expectancies. So, for August’s poll, we asked, ‘How Significant Will the Impact of the Latest CMI Data on UK Life Expectancy Be on Life Risk Markets? ’

    The US Centers for Disease and Control (CDC) tracks all causes of death and has published provisional summary for 2022 deaths, including Covid-19 related deaths. However, the life insurance subset is generally a higher economic demographic subset with longer than average life expectancies, and John Lynch, Director of Actuarial & Underwriting Services, Longevity Holdings, takes a closer look at where Covid-19 and life settlements meet in Covid-19 Excess Mortality Analysis, our second commentary piece this month.

    The involvement of the capital markets in terms of its capability to absorb longevity risk has been talked about for years, but action has been largely absent. Greg Winterton caught up with David Blake, Professor of Finance & Director of the Pensions Institute, Bayes Business School, to get his thoughts on the current state of the longevity financing conundrum in this month’s Q&A.

    Participants in the UK equity release market – insurance companies, advisers and consultants – generally agree that the industry has something of an awareness challenge. But the current macroeconomic environment is changing that, and Greg Winterton spoke to Rudy Khaitan, Managing Partner at Senior Capital, Ben Grainger, Partner at EY, and Steve Kyle, Secretary General of European Pensions and Property Asset Release Group, to get their views on the outlook for growth in the market in Equity Release Fundamentals Underpin Growth Opportunity.

    I hope you enjoy the latest issue of Life Risk News.

    Chris Wells
    Managing Editor
    Life Risk News

    2023 - September Editor's Letter Volume 2 Issue 9 - September 2023
    Share. Twitter LinkedIn Email

    Related Posts

    Editor’s Letter – Volume 2, Issue 7, July 2026

    July 8, 2026By Chris Wells

    Editor’s Letter – Volume 2, Issue 6, June 2026

    June 10, 2026By Chris Wells

    Editor’s Letter – Volume 2, Issue 5, May 2026

    May 13, 2026By Chris Wells

    Editor’s Letter – Volume 2, Issue 4, April 2026

    April 9, 2026By Chris Wells
    Latest Issue

    Optimism for Stronger Second Half in the Life Settlement Tertiary Market

    July 8, 2026

    Organ Transplant Improvements Test Life Expectancy Assessment Models

    July 8, 2026

    US Life Insurers Embrace Securitised Credit as Demand for Yield and Diversification Grows but Hurdles Remain for Longevity-Linked Assets

    July 8, 2026

    Passage of UK Pension Schemes Act Seen Boosting Size of DB Superfund Market

    June 24, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.